Cargando…
Phase II biomarker trial of a multimarker diagnostic for ovarian cancer
PURPOSE: The primary hypothesis to be tested in this study was that the diagnostic performance (as assessed by the area under the receiver operator characteristic curve, AUC) of a multianalyte panel to correctly identify women with ovarian cancer was significantly greater than that for CA-125 alone....
Autores principales: | Edgell, Tracey, Martin-Roussety, G., Barker, G., Autelitano, D. J., Allen, D., Grant, P., Rice, G. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874491/ https://www.ncbi.nlm.nih.gov/pubmed/20082099 http://dx.doi.org/10.1007/s00432-009-0755-5 |
Ejemplares similares
-
Evaluation of midkine and anterior gradient 2 in a multimarker panel for the detection of ovarian cancer
por: Rice, Gregory E, et al.
Publicado: (2010) -
The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
por: Topf, Albert, et al.
Publicado: (2020) -
Improved early detection of ovarian cancer using longitudinal multimarker models
por: Whitwell, Harry J., et al.
Publicado: (2020) -
Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel
por: Park, Jiyoung, et al.
Publicado: (2017) -
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation
por: Pol, Tymon, et al.
Publicado: (2021)